CAMBER CAPITAL MANAGEMENT LP Holdings

CAMBER CAPITAL MANAGEMENT LP is an investment fund managing more than 3.27B US dollars. The largest holdings include Sanofi, Viatris and Universal Health Services. In Q3 2022 the fund bought assets of total value of 869.07M US dollars and sold assets of total value of 200.06M US dollars.

$3.26B

portfolio value

-2.09%

quarter

-19.83%

1 year

+42.09%

3 years

+117.27%

5 years

CAMBER CAPITAL MANAGEMENT LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	415212000	270981000
Q2 2016	558756000	449079000
Q3 2016	252549000	323542000
Q4 2016	295798000	295333000
Q1 2017	164157000	222952000
Q2 2017	254319000	337639000
Q3 2017	354033000	540879000
Q4 2017	400578000	168832000
Q1 2018	698970000	146627000
Q2 2018	245640000	285863000
Q3 2018	181065000	594250000
Q4 2018	357226000	67405000
Q1 2019	380523000	425924000
Q2 2019	347243000	347740000
Q3 2019	360989000	255725000
Q4 2019	328550000	203218000
Q1 2020	517287000	417580000
Q2 2020	444194000	466159000
Q3 2020	422023000	262903000
Q4 2020	772194000	66299000
Q1 2021	661124000	549429000
Q2 2021	592396000	551206000
Q3 2021	525266000	301015000
Q4 2021	543457000	585096000
Q1 2022	612946000	469932000
Q2 2022	417684000	739065000
Q3 2022	869074000	200059000

CAMBER CAPITAL MANAGEMENT LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—General Sanofi Portfolio share: 8.73% Portfolio value: 285.15M Avg. open price: $49.98 Current price: $44.93 P/L: -10.10% Bought +87.50% shares Q3 2022	share	8.73%	285.15M	$49.98	$44.93	-10.10%	Bought +87.50% shares Q3 2022
Drug Manufacturers—Specialty & Generic Viatris Inc. Portfolio share: 7.83% Portfolio value: 255.6M Avg. open price: $12.33 Current price: $10.92 P/L: -11.42% Bought +30.43% shares Q3 2022	share	7.83%	255.6M	$12.33	$10.92	-11.42%	Bought +30.43% shares Q3 2022
Medical Care Facilities Universal Health Services, Inc. Portfolio share: 6.08% Portfolio value: 198.40M Avg. open price: $119.5 Current price: $127.36 P/L: +6.58% Bought +202.01% shares Q3 2022	share	6.08%	198.40M	$119.5	$127.36	+6.58%	Bought +202.01% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 5.08% Portfolio value: 165.81M Avg. open price: $97.43 Current price: $122.96 P/L: +26.21% Sold -18.92% shares Q3 2022	share	5.08%	165.81M	$97.43	$122.96	+26.21%	Sold -18.92% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 4.74% Portfolio value: 154.74M Avg. open price: $34.38 Current price: $44.6 P/L: +29.72% Bought +81.82% shares Q3 2022	share	4.74%	154.74M	$34.38	$44.6	+29.72%	Bought +81.82% shares Q3 2022
Medical Devices Zimmer Biomet Holdings, Inc. Portfolio share: 4.48% Portfolio value: 146.37M Avg. open price: $133.92 Current price: $122.3 P/L: -8.68% Bought +3.70% shares Q3 2022	share	4.48%	146.37M	$133.92	$122.3	-8.68%	Bought +3.70% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 4.28% Portfolio value: 139.68M Avg. open price: $107.45 Current price: $92.75 P/L: -13.68% Bought +207.69% shares Q3 2022	share	4.28%	139.68M	$107.45	$92.75	-13.68%	Bought +207.69% shares Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 3.96% Portfolio value: 129.18M Avg. open price: $74.23 Current price: $110.01 P/L: +48.20% N/A Q3 2022	call	3.96%	129.18M	$74.23	$110.01	+48.20%	N/A Q3 2022
Biotechnology PTC Therapeutics, Inc. Portfolio share: 3.77% Portfolio value: 122.99M Avg. open price: $26.99 Current price: $41.12 P/L: +52.34% Bought +40.00% shares Q2 2022	share	3.77%	122.99M	$26.99	$41.12	+52.34%	Bought +40.00% shares Q2 2022
Drug Manufacturers—General Pfizer Inc. Portfolio share: 3.35% Portfolio value: 109.4M Avg. open price: N/A Current price: $50.73 P/L: N/A N/A Q3 2022	call	3.35%	109.4M	N/A	$50.73	N/A	N/A Q3 2022
Medical Care Facilities Select Medical Holdings Corporation Portfolio share: 3.25% Portfolio value: 106.08M Avg. open price: $20.35 Current price: $24.3 P/L: +19.40% Bought +20.00% shares Q3 2022	share	3.25%	106.08M	$20.35	$24.3	+19.40%	Bought +20.00% shares Q3 2022
Diagnostics & Research Charles River Laboratories International, Inc. Portfolio share: 3.01% Portfolio value: 98.4M Avg. open price: N/A Current price: $215.11 P/L: N/A N/A Q3 2022	share	3.01%	98.4M	N/A	$215.11	N/A	N/A Q3 2022
Diagnostics & Research Myriad Genetics, Inc. Portfolio share: 2.92% Portfolio value: 95.4M Avg. open price: $20.67 Current price: $20.01 P/L: -3.19% Bought +42.86% shares Q2 2022	share	2.92%	95.4M	$20.67	$20.01	-3.19%	Bought +42.86% shares Q2 2022
Drug Manufacturers—Specialty & Generic Perrigo Company plc Portfolio share: 2.73% Portfolio value: 89.15M Avg. open price: $59.79 Current price: $31.81 P/L: -46.79% Sold -9.09% shares Q3 2022	share	2.73%	89.15M	$59.79	$31.81	-46.79%	Sold -9.09% shares Q3 2022
Pharmaceutical Retailers Walgreens Boots Alliance, Inc. Portfolio share: 2.72% Portfolio value: 88.70M Avg. open price: $43.96 Current price: $41.21 P/L: -6.25% Bought +17.71% shares Q2 2022	share	2.72%	88.70M	$43.96	$41.21	-6.25%	Bought +17.71% shares Q2 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 2.61% Portfolio value: 85.14M Avg. open price: $36.68 Current price: $38.98 P/L: +6.27% Sold -28.70% shares Q3 2022	share	2.61%	85.14M	$36.68	$38.98	+6.27%	Sold -28.70% shares Q3 2022
Drug Manufacturers—General GSK plc Portfolio share: 2.25% Portfolio value: 73.57M Avg. open price: $35.05 Current price: $35.16 P/L: +0.30% N/A Q3 2022	share	2.25%	73.57M	$35.05	$35.16	+0.30%	N/A Q3 2022
Medical Care Facilities Brookdale Senior Living Inc. Portfolio share: 2.09% Portfolio value: 68.32M Avg. open price: $9.58 Current price: $3.34 P/L: -65.12% Bought +4.23% shares Q3 2021	share	2.09%	68.32M	$9.58	$3.34	-65.12%	Bought +4.23% shares Q3 2021
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 2.08% Portfolio value: 67.81M Avg. open price: $84.14 Current price: $103.53 P/L: +23.05% Sold -46.67% shares Q3 2022	share	2.08%	67.81M	$84.14	$103.53	+23.05%	Sold -46.67% shares Q3 2022
Health Information Services Change Healthcare Inc. Portfolio share: 1.96% Portfolio value: 63.91M Avg. open price: $16.77 Current price: $27.49 P/L: +63.95% Sold -61.25% shares Q2 2022	share	1.96%	63.91M	$16.77	$27.49	+63.95%	Sold -61.25% shares Q2 2022
Drug Manufacturers—Specialty & Generic Teva Pharmaceutical Industries Limited Portfolio share: 1.85% Portfolio value: 60.52M Avg. open price: $21.44 Current price: $8.62 P/L: -59.79% Bought +172.73% shares Q3 2022	share	1.85%	60.52M	$21.44	$8.62	-59.79%	Bought +172.73% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 1.64% Portfolio value: 53.4M Avg. open price: $271.98 Current price: $292.75 P/L: +7.64% Bought +60.00% shares Q3 2022	share	1.64%	53.4M	$271.98	$292.75	+7.64%	Bought +60.00% shares Q3 2022
Biotechnology Incyte Corporation Portfolio share: 1.53% Portfolio value: 49.98M Avg. open price: $74.11 Current price: $84.08 P/L: +13.45% Sold -37.50% shares Q3 2022	share	1.53%	49.98M	$74.11	$84.08	+13.45%	Sold -37.50% shares Q3 2022
Medical Care Facilities Cano Health, Inc. Portfolio share: 1.33% Portfolio value: 43.35M Avg. open price: $4.38 Current price: $2.09 P/L: -52.28% Bought +66.67% shares Q3 2022	share	1.33%	43.35M	$4.38	$2.09	-52.28%	Bought +66.67% shares Q3 2022
Medical Instruments & Supplies QuidelOrtho Corporation Portfolio share: 1.31% Portfolio value: 42.88M Avg. open price: N/A Current price: $93.6 P/L: N/A N/A Q3 2022	share	1.31%	42.88M	N/A	$93.6	N/A	N/A Q3 2022
Medical Devices Align Technology, Inc. Portfolio share: 1.27% Portfolio value: 41.42M Avg. open price: $236.67 Current price: $187.96 P/L: -20.58% Bought +100.00% shares Q3 2022	share	1.27%	41.42M	$236.67	$187.96	-20.58%	Bought +100.00% shares Q3 2022
Medical Devices Medtronic plc Portfolio share: 1.24% Portfolio value: 40.37M Avg. open price: N/A Current price: $78.79 P/L: N/A N/A Q3 2022	share	1.24%	40.37M	N/A	$78.79	N/A	N/A Q3 2022
Medical Instruments & Supplies DENTSPLY SIRONA Inc. Portfolio share: 1.23% Portfolio value: 40.11M Avg. open price: $35.73 Current price: $30.63 P/L: -14.27% Bought +13.20% shares Q3 2022	share	1.23%	40.11M	$35.73	$30.63	-14.27%	Bought +13.20% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 1.16% Portfolio value: 38.02M Avg. open price: $49.98 Current price: $44.93 P/L: -10.10% N/A Q3 2022	call	1.16%	38.02M	$49.98	$44.93	-10.10%	N/A Q3 2022
Biotechnology Seagen Inc. Portfolio share: 1.05% Portfolio value: 34.20M Avg. open price: N/A Current price: $121.22 P/L: N/A N/A Q3 2022	share	1.05%	34.20M	N/A	$121.22	N/A	N/A Q3 2022
Medical Devices Quanterix Corporation Portfolio share: 1.01% Portfolio value: 33.06M Avg. open price: $16.19 Current price: $13 P/L: -19.70% Bought +162.77% shares Q3 2022	share	1.01%	33.06M	$16.19	$13	-19.70%	Bought +162.77% shares Q3 2022
Medical Devices ZimVie Inc. Portfolio share: 0.79% Portfolio value: 25.66M Avg. open price: $16.01 Current price: $9.16 P/L: -42.79% Bought +30.00% shares Q3 2022	share	0.79%	25.66M	$16.01	$9.16	-42.79%	Bought +30.00% shares Q3 2022
Medical Devices NuVasive, Inc. Portfolio share: 0.67% Portfolio value: 21.90M Avg. open price: $53.11 Current price: $39.63 P/L: -25.37% Bought +400.00% shares Q1 2022	share	0.67%	21.90M	$53.11	$39.63	-25.37%	Bought +400.00% shares Q1 2022
Biotechnology Exelixis, Inc. Portfolio share: 0.65% Portfolio value: 21.16M Avg. open price: $22.67 Current price: $17.22 P/L: -24.04% Sold -18.18% shares Q3 2022	share	0.65%	21.16M	$22.67	$17.22	-24.04%	Sold -18.18% shares Q3 2022
Leisure Peloton Interactive, Inc. Portfolio share: 0.64% Portfolio value: 20.79M Avg. open price: N/A Current price: $12.92 P/L: N/A N/A Q3 2022	share	0.64%	20.79M	N/A	$12.92	N/A	N/A Q3 2022
Medical Devices Inogen, Inc. Portfolio share: 0.61% Portfolio value: 20.03M Avg. open price: $33.28 Current price: $21.4 P/L: -35.70% Bought +10.00% shares Q2 2022	share	0.61%	20.03M	$33.28	$21.4	-35.70%	Bought +10.00% shares Q2 2022
Medical Devices Glaukos Corporation Portfolio share: 0.57% Portfolio value: 18.63M Avg. open price: $45.59 Current price: $45.88 P/L: +0.63% Bought +87.14% shares Q3 2022	share	0.57%	18.63M	$45.59	$45.88	+0.63%	Bought +87.14% shares Q3 2022
Medical Devices Cardiovascular Systems, Inc. Portfolio share: 0.55% Portfolio value: 18.01M Avg. open price: $18.4 Current price: $13.65 P/L: -25.81% Bought +38.24% shares Q3 2022	share	0.55%	18.01M	$18.4	$13.65	-25.81%	Bought +38.24% shares Q3 2022
Biotechnology Zymeworks Inc. Portfolio share: 0.54% Portfolio value: 17.62M Avg. open price: $13.49 Current price: $7.62 P/L: -43.51% Bought +43.25% shares Q3 2022	share	0.54%	17.62M	$13.49	$7.62	-43.51%	Bought +43.25% shares Q3 2022
Drug Manufacturers—Specialty & Generic Collegium Pharmaceutical, Inc. Portfolio share: 0.52% Portfolio value: 16.82M Avg. open price: N/A Current price: $22.73 P/L: N/A Sold -47.50% shares Q4 2021	share	0.52%	16.82M	N/A	$22.73	N/A	Sold -47.50% shares Q4 2021
Medical Instruments & Supplies OraSure Technologies, Inc. Portfolio share: 0.49% Portfolio value: 16.10M Avg. open price: $10.91 Current price: $5.06 P/L: -53.63% Bought +18.88% shares Q3 2021	share	0.49%	16.10M	$10.91	$5.06	-53.63%	Bought +18.88% shares Q3 2021
Medical Instruments & Supplies NanoString Technologies, Inc. Portfolio share: 0.39% Portfolio value: 12.77M Avg. open price: $12.7 Current price: $7.06 P/L: -44.41% Bought +17.65% shares Q3 2022	share	0.39%	12.77M	$12.7	$7.06	-44.41%	Bought +17.65% shares Q3 2022
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 0.38% Portfolio value: 12.56M Avg. open price: $131.99 Current price: $39.62 P/L: -69.98% Sold -66.67% shares Q3 2022	share	0.38%	12.56M	$131.99	$39.62	-69.98%	Sold -66.67% shares Q3 2022
Medical Care Facilities Oak Street Health, Inc. Portfolio share: 0.38% Portfolio value: 12.40M Avg. open price: N/A Current price: $21.94 P/L: N/A N/A Q3 2022	share	0.38%	12.40M	N/A	$21.94	N/A	N/A Q3 2022
Biotechnology Puma Biotechnology, Inc. Portfolio share: 0.31% Portfolio value: 10.03M Avg. open price: $10.83 Current price: $4.31 P/L: -60.20% Bought +5.88% shares Q2 2022	share	0.31%	10.03M	$10.83	$4.31	-60.20%	Bought +5.88% shares Q2 2022
Biotechnology 2seventy bio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $15.36 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$15.36	N/A	Sold -100.00% shares Q3 2022
Medical Devices Pacific Biosciences of California, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.45 Current price: $10.03 P/L: +190.72% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.45	$10.03	+190.72%	Sold -100.00% shares Q3 2022
Diagnostics & Research Exact Sciences Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $45.55 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$45.55	N/A	Sold -100.00% shares Q3 2022
Health Information Services Evolent Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $32.3 Current price: $28.66 P/L: -11.27% Sold -100.00% shares Q3 2022	share	0.00%	0	$32.3	$28.66	-11.27%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies SmileDirectClub, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.44 Current price: $0.52 P/L: -78.58% Sold -100.00% shares Q3 2022	share	0.00%	0	$2.44	$0.52	-78.58%	Sold -100.00% shares Q3 2022

Showing TOP 50 CAMBER CAPITAL MANAGEMENT LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of CAMBER CAPITAL MANAGEMENT LP?

The biggest position of the CAMBER CAPITAL MANAGEMENT LP is Sanofi (SNY) with 8.73% portfolio share worth of 285.15M US dollars.

Top 5 CAMBER CAPITAL MANAGEMENT LP's holdings represent 32.45% of the portfolio:

Sanofi (SNY) – 8.73%
Viatris Inc. (VTRS) – 7.83%
Universal Health Services, Inc. (UHS) – 6.08%
Sarepta Therapeutics, Inc. (SRPT) – 5.08%
Tenet Healthcare Corporation (THC) – 4.74%

Who is the portfolio manager of CAMBER CAPITAL MANAGEMENT LP?

The portfolio manager of the CAMBER CAPITAL MANAGEMENT LP is .

What is the total asset value of the CAMBER CAPITAL MANAGEMENT LP portfolio?

CAMBER CAPITAL MANAGEMENT LP total asset value (portfolio value) is 3.27B US dollars.

Who is ?

is the portfolio manager of the CAMBER CAPITAL MANAGEMENT LP.

What is (CAMBER CAPITAL MANAGEMENT LP) fund performance?

CAMBER CAPITAL MANAGEMENT LP's quarterly performance is -2.09%, annualy -19.83%. In the past 3 years, the value of 's portfolio has increased by +42%. In the past 5 years, the value of the portfolio has increased by +117%.

What is the CAMBER CAPITAL MANAGEMENT LP CIK?

CAMBER CAPITAL MANAGEMENT LP's Central Index Key is 0001444043 .

CAMBER CAPITAL MANAGEMENT LP Holdings

CAMBER CAPITAL MANAGEMENT LP portfolio value:

CAMBER CAPITAL MANAGEMENT LP quarter portfolio value change:

CAMBER CAPITAL MANAGEMENT LP 1 year portfolio value change:

CAMBER CAPITAL MANAGEMENT LP 3 years portfolio value change:

CAMBER CAPITAL MANAGEMENT LP 5 years portfolio value change: